Search

Your search keyword '"Maria, Serpente"' showing total 107 results

Search Constraints

Start Over You searched for: Author "Maria, Serpente" Remove constraint Author: "Maria, Serpente"
107 results on '"Maria, Serpente"'

Search Results

1. A systematic review of progranulin concentrations in biofluids in over 7,000 people—assessing the pathogenicity of GRN mutations and other influencing factors

2. Distribution of the C9orf72 hexanucleotide repeat expansion in healthy subjects: a multicenter study promoted by the Italian IRCCS network of neuroscience and neurorehabilitation

3. Aquaporin-4 cerebrospinal fluid levels are higher in neurodegenerative dementia: looking at glymphatic system dysregulation

4. Association between enlarged perivascular spaces and cerebrospinal fluid aquaporin-4 and tau levels: report from a memory clinic

5. Letter to the editor on a paper by Kaivola et al. (2020): carriership of two copies of C9orf72 hexanucleotide repeat intermediate-length alleles is not associated with amyotrophic lateral sclerosis or frontotemporal dementia

6. A Novel Automated Chemiluminescence Method for Detecting Cerebrospinal Fluid Amyloid-Beta 1-42 and 1-40, Total Tau and Phosphorylated-Tau: Implications for Improving Diagnostic Performance in Alzheimer’s Disease

7. The Role of Glymphatic System in Alzheimer’s and Parkinson’s Disease Pathogenesis

8. miR-150-5p and let-7b-5p in Blood Myeloid Extracellular Vesicles Track Cognitive Symptoms in Patients with Multiple Sclerosis

9. Exosome Determinants of Physiological Aging and Age-Related Neurodegenerative Diseases

10. New insights into the genetic etiology of Alzheimer's disease and related dementias

11. MiRNA Profiling in Plasma Neural-Derived Small Extracellular Vesicles from Patients with Alzheimer’s Disease

12. Analysis of C9orf72 Intermediate Alleles in a Retrospective Cohort of Neurological Patients: Risk Factors for Alzheimer’s Disease?

13. Anti-Cholinergic Derangement of Cortical Metabolism on 18F-FDG PET in a Patient with Frontotemporal Lobar Degeneration Dementia: A Case of the TREDEM Registry

14. miRNA Expression Is Increased in Serum from Patients with Semantic Variant Primary Progressive Aphasia

15. Circulating Non-Coding RNA Levels Are Altered in Autosomal Dominant Frontotemporal Dementia

16. SLITRK2, an X-linked modifier of the age at onset in C9orf72 frontotemporal lobar degeneration

17. Inflammatory expression profile in peripheral blood mononuclear cells from patients with Nasu-Hakola Disease

18. Monozygotic Twins with Frontotemporal Dementia Due To Thr272fs GRN Mutation Discordant for Age At Onset

19. Genetic variation in APOE, GRN, and TP53 are phenotype modifiers in frontotemporal dementia

20. Gene Expression Imputation Across Multiple Tissue Types Provides Insight Into the Genetic Architecture of Frontotemporal Dementia and Its Clinical Subtypes

21. Detection of the SQSTM1 Mutation in a Patient with Early-Onset Hippocampal Amnestic Syndrome

22. Phenotypic heterogeneity of the rare R377W PSEN1 mutation: Late‐onset presentation with mixed Alzheimer’s and frontotemporal dementia features

23. Late-onset presentation and phenotypic heterogeneity of the rare R377W PSEN1 mutation

24. Pathogenic huntingtin repeat expansions in patients with frontotemporal dementia and amyotrophic lateral sclerosis

25. Mendelian randomization implies no direct causal association between leukocyte telomere length and amyotrophic lateral sclerosis

26. Progranulin gene variability and plasma levels in bipolar disorder and schizophrenia.

27. LncRNAs expression profile in peripheral blood mononuclear cells from multiple sclerosis patients

28. Role of Genetics and Epigenetics in the Pathogenesis of Alzheimer’s Disease and Frontotemporal Dementia

29. A case of bipolar disorder developing into atypical parkinsonism and presenting with frontotemporal asymmetrical brain degeneration. A TREDEM Registry Case Report

30. Cerebrospinal Fluid Level of Aquaporin4: A New Window on Glymphatic System Involvement in Neurodegenerative Disease?

31. Role for ATXN1, ATXN2, and HTT intermediate repeats in frontotemporal dementia and Alzheimer's disease

32. A Case with Early Onset Alzheimer's Disease, Frontotemporal Hypometabolism, ApoE Genotype ɛ4/ɛ4 and C9ORF72 Intermediate Expansion: A Treviso Dementia (TREDEM) Registry Case Report

33. MiRNA Profiling in Plasma Neural-Derived Small Extracellular Vesicles from Patients with Alzheimer’s Disease

34. C9ORF72 hexanucleotide repeat expansion frequency in patients with Paget's disease of bone

35. A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer’s disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity

36. Amyloid PET as a marker of normal-appearing white matter early damage in multiple sclerosis: correlation with CSF β-amyloid levels and brain volumes

37. Integrative system biology analyses of CRISPR-edited iPSC-derived neurons and human brains reveal deficiencies of presynaptic signaling in FTLD and PSP

38. Rapidly progressive primary progressive aphasia and parkinsonism with novel GRN mutation

39. Effect of fingolimod treatment on circulating miR-15b, miR23a and miR-223 levels in patients with multiple sclerosis

40. Profiling of Specific Gene Expression Pathways in Peripheral Cells from Prodromal Alzheimer's Disease Patients

41. Autosomal Dominant Frontotemporal Lobar Degeneration: From Genotype to Phenotype

42. Progranulin plasma levels predict the presence of GRN mutations in asymptomatic subjects and do not correlate with brain atrophy: results from the GENFI study

44. Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease

45. Evidence of CNS β-amyloid deposition in Nasu-Hakola disease due to the

46. Transmembrane Protein 106B Gene (TMEM106B) Variability and Influence on Progranulin Plasma Levels in Patients with Alzheimer's Disease

47. Phenotypic Variability associated with the C9ORF72 Hexanucleotide Repeat Expansion: A Sporadic Case of Frontotemporal Lobar Degeneration with Prodromal Hyposmia and Predominant Semantic Deficits

48. Incomplete Penetrance of the C9ORF72 Hexanucleotide Repeat Expansions: Frequency in a Cohort of Geriatric Non-Demented Subjects

49. Innate Immune System and Inflammation in Alzheimer's Disease: From Pathogenesis to Treatment

50. Novel Evidence of Phenotypical Variability in the Hexanucleotide Repeat Expansion in Chromosome 9

Catalog

Books, media, physical & digital resources